Holen Sie sich die Stockscreener-App
2.53
3.28%
-0.09
Finanzdaten der Zentalis Pharmaceuticals Inc-Aktie (ZNTL)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | 26.86 | - |
Operating Expenses
|
6.45%
33.73
|
36.06 | 45.62 | 76.71 | 51.43 |
| Operating Income/Loss |
6.45%
-33.73
|
-36.06 | -45.62 | -49.85 | -51.43 |
| Income/Loss From Continuing Operations Before Tax |
0.68%
-26.69
|
-26.87 | -48.28 | -47.68 | -40.19 |
| Income Tax Expense/Benefit |
-
|
- | - | -0.205 | -0.027 |
| Income/Loss From Continuing Operations After Tax |
0.68%
-26.69
|
-26.87 | -48.28 | -47.47 | -40.16 |
|
Net Income/Loss
|
0.68%
-26.69
|
-26.87 | -48.28 | -47.47 | -40.16 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.20%
72.14
|
71.99 | 71.68 | 0.063 | 71.11 |
| Diluted Average Shares |
0.20%
72.14
|
71.99 | 71.68 | 0.063 | 71.11 |
| Basic Earnings Per Share |
0.00%
-0.37
|
-0.37 | -0.67 | -0.66 | -0.56 |
| Diluted Earnings Per Share |
0.00%
-0.37
|
-0.37 | -0.67 | -0.66 | -0.56 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.34%
1.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):